• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Dr Oz to face Senate grilling on Capitol Hill in bid to run Centers for Medicare and Medicaid

by March 14, 2025
written by March 14, 2025

Dr. Mehmet Oz, President Donald Trump’s pick to lead the Centers for Medicare and Medicaid, will face questions in front of the Senate Committee on Finance Friday morning. 

Following the hearing, the committee will schedule a vote to send Oz’s nomination to the full Senate, where approval is likely, considering the Republican majority.

If confirmed, Oz would be in charge of nearly $1.5 trillion in federal healthcare spending. Medicare, a federal healthcare program for seniors aged 65 and up, currently provides coverage for about 65 million Americans, according to the Center for Medicare Advocacy. Medicaid, which assists people with low incomes, covers roughly 72 million Americans, according to Medicaid.gov.

A former heart surgeon who saw his fame rise through his appearances on daytime TV and 13 seasons of ‘The Dr Oz Show,’ Oz later transitioned into politics, launching an unsuccessful bid for Pennsylvania’s open Senate seat in 2022. He ultimately lost to John Fetterman, then the state’s lieutenant governor. Oz graduated from Harvard and received medical and business degrees from the University of Pennsylvania. 

Oz is expected to be grilled by Democrats during the hearing over his financial ties to a myriad of healthcare-related companies, several of which pose potential conflicts of interest for the potential CMS director.

Oz has committed to divesting many of his financial interests that pose the most obvious risk of impropriety, such as his hundreds of thousands of dollars in stock in United Health Group, a major private health insurer. He also said that if he were confirmed, he would forfeit the nearly $25 million in stock options he obtained as an advisor to a company selling health and beauty supplements.

As the administrator of CMS, Oz would make decisions related to how the government covers procedures, hospital stays and medication within the federal healthcare programs, as well as the reimbursement rates at which healthcare providers get paid for their services. 

On Thursday, Trump’s pick to lead the NIH and FDA, Dr. Jay Bhattacharya and Dr. Marty Makary, respectively, were approved in committee and will now face impending votes by the full Senate.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Dollar General CEO warns consumers are cash-strapped and says 2025 won’t be better
next post
Senate to take up Trump spending bill as clock ticks down to government shutdown

related articles

Cambodia to nominate Trump for Nobel Peace Prize...

August 2, 2025

WATCH: Trump says he is hopeful Hillary Clinton...

August 1, 2025

Recess on ice as Republicans hunker down for...

August 1, 2025

Trump moves nuclear submarines weeks after praising sub’s...

August 1, 2025

Iran says it has ‘plenty of scientists’ left...

August 1, 2025

Trump endorses ‘MAGA warrior’ for RNC chairman after...

August 1, 2025

Trump repositions 2 nuclear submarines after ‘highly provocative’...

August 1, 2025

Kavanaugh cites 3 presidents in explaining Supreme Court’s...

August 1, 2025

China’s growing nuclear arsenal aims to break US...

August 1, 2025

Trump ally Bukele’s party amends El Salvador constitution...

August 1, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • Experts warn Iran could have a nuclear bomb before the next president takes office

    September 6, 2024
  • Bitcoin hits $76K, Dogecoin dips: Crypto prices surge on Trump victory

    November 7, 2024
  • Trump official blasts Washington Post for ‘fake news’ reporting about DOGE firings

    February 28, 2025
  • Krispy Kreme stock plunges after doughnut chain pauses McDonald’s rollout, pulls outlook

    May 8, 2025
  • ETH vs ETHA vs ETHV vs FETH: Best Ethereum ETF to buy?

    July 23, 2024

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (5,603)
  • Investing (634)
  • Stock (867)

Latest Posts

  • Trump rescinds Biden-era policy declaring DEI an ‘integral’ part of scientific process

    March 20, 2025
  • Tufts University accused of severing ties with House Democrat over trans athlete comments

    November 12, 2024
  • ‘Watermelon head’: Trump trolls Democratic Sen Schiff

    April 9, 2025

Recent Posts

  • RFK Jr. asks Americans to suggest policies for new Trump administration: ‘Transition team belongs to YOU’

    November 14, 2024
  • Democrats elect new chair who branded Trump a ‘traitor’ as party aims to rebound from disastrous 2024 election

    February 1, 2025
  • SafeMoon and Litecoin: Targets and Prices for Thursday

    October 3, 2024

Editor’s Pick

  • Challenges posed by Trump and Putin push UK to adopt new NATO first defense policy

    June 3, 2025
  • Bitwise seeks approval for ETF tracking companies holding over 1,000 BTC

    December 27, 2024
  • The Israeli-Iranian war is not over—it has just entered a dangerous pause

    June 25, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock